{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:14:20Z","timestamp":1791994460187,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the CAMS Innovation Fund for Medical Sciences","award":["2021-1-I2M-026"],"award-info":[{"award-number":["2021-1-I2M-026"]}]},{"name":"Anhui University of Chinese Medicine Foundation","award":["No. 2023rcZD003"],"award-info":[{"award-number":["No. 2023rcZD003"]}]},{"name":"the Key Project of Anhui Province Department of Education","award":["No. 2022AH050506"],"award-info":[{"award-number":["No. 2022AH050506"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03127-1","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T01:27:19Z","timestamp":1738027639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A new NCL-targeting aptamer-drug conjugate as a promising therapy against esophageal cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Xue","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"3127_CR1","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.7150\/ijbs.85753","volume":"19","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhang J, Luan S, Liu Z, Li X, Liu B, Yuan Y. Unraveling the complexity of regulated cell death in Esophageal Cancer: from underlying mechanisms to targeted therapeutics. Int J Biol Sci. 2023;19:3831\u201368.","journal-title":"Int J Biol Sci"},{"key":"3127_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, Laversanne M, Ferlay J, Arnold M. The Global Landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163:649\u2013e658642.","journal-title":"Gastroenterology"},{"key":"3127_CR3","doi-asserted-by":"publisher","first-page":"e074962","DOI":"10.1136\/bmj-2023-074962","volume":"385","author":"N Deboever","year":"2024","unstructured":"Deboever N, Jones CM, Yamashita K, Ajani JA, Hofstetter WL. Advances in diagnosis and management of cancer of the esophagus. BMJ. 2024;385:e074962.","journal-title":"BMJ"},{"key":"3127_CR4","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/j.apsb.2021.03.008","volume":"11","author":"S He","year":"2021","unstructured":"He S, Xu J, Liu X, Zhen Y. Advances and challenges in the treatment of esophageal cancer. Acta Pharm Sinica B. 2021;11:3379\u201392.","journal-title":"Acta Pharm Sinica B"},{"key":"3127_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41416-021-01485-9","volume":"126","author":"JC Bolger","year":"2021","unstructured":"Bolger JC, Donohoe CL, Lowery M, Reynolds JV. Advances in the curative management of oesophageal cancer. Br J Cancer. 2021;126:706\u201317.","journal-title":"Br J Cancer"},{"key":"3127_CR6","doi-asserted-by":"crossref","unstructured":"An L, Li M, Jia Q. Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma. Mol Cancer 2023, 22.","DOI":"10.1186\/s12943-023-01839-2"},{"key":"3127_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41392-020-00323-3","volume":"5","author":"YM Yang","year":"2020","unstructured":"Yang YM, Hong P, Xu WW, He QY, Li B. Advances in targeted therapy for esophageal cancer. Signal Transduct Target Ther. 2020;5:229.","journal-title":"Signal Transduct Target Ther"},{"key":"3127_CR8","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1021\/acs.accounts.3c00309","volume":"56","author":"Y Tao","year":"2023","unstructured":"Tao Y, Jakobsson V, Chen X, Zhang J. Exploiting albumin as a versatile carrier for Cancer Theranostics. Acc Chem Res. 2023;56:2403\u201315.","journal-title":"Acc Chem Res"},{"key":"3127_CR9","doi-asserted-by":"crossref","unstructured":"Shi Z, Luo M, Huang Q, Ding C, Wang W, Wu Y, Luo J, Lin C, Chen T, Zeng X et al. NIR-dye bridged human serum albumin reassemblies for effective photothermal therapy of tumor. Nat Commun 2023, 14.","DOI":"10.1038\/s41467-023-42399-9"},{"key":"3127_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jconrel.2021.08.049","volume":"338","author":"Y Xu","year":"2021","unstructured":"Xu Y, Liu Y, Liu Q, Lu S, Chen X, Xu W, Shi F. Co-delivery of bufalin and nintedanib via albumin sub-microspheres for synergistic cancer therapy. J Controlled Release. 2021;338:705\u201318.","journal-title":"J Controlled Release"},{"key":"3127_CR11","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1080\/10717544.2022.2063454","volume":"29","author":"S He","year":"2022","unstructured":"He S, Zhao C, Tao H, Sheng W, Gao R, Liu X, Zhen Y. A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer. Drug Delivery. 2022;29:1243\u201356.","journal-title":"Drug Delivery"},{"key":"3127_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijbiomac.2020.02.106","volume":"152","author":"A Akbarian","year":"2020","unstructured":"Akbarian A, Ebtekar M, Pakravan N, Hassan ZM. Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles. Int J Biol Macromol. 2020;152:90\u2013101.","journal-title":"Int J Biol Macromol"},{"key":"3127_CR13","doi-asserted-by":"publisher","first-page":"12035","DOI":"10.1021\/acs.chemrev.0c01140","volume":"121","author":"L Wu","year":"2021","unstructured":"Wu L, Wang Y, Xu X, Liu Y, Lin B, Zhang M, Zhang J, Wan S, Yang C, Tan W. Aptamer-based detection of circulating targets for Precision Medicine. Chem Rev. 2021;121:12035\u2013105.","journal-title":"Chem Rev"},{"key":"3127_CR14","doi-asserted-by":"crossref","unstructured":"Liu B, Liu J, Hu X, Xiang W, Hou W, Li C, Wang J, Yao K, Tang J, Long Z et al. Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells. Mater Today Bio 2023, 19.","DOI":"10.1016\/j.mtbio.2023.100605"},{"key":"3127_CR15","doi-asserted-by":"crossref","unstructured":"He S, Du Y, Tao H, Duan H. Advances in aptamer-mediated targeted delivery system for cancer treatment. Int J Biol Macromol 2023, 238.","DOI":"10.1016\/j.ijbiomac.2023.124173"},{"key":"3127_CR16","doi-asserted-by":"crossref","unstructured":"Li C, Shi K, Zhao S, Liu J, Zhai Q, Hou X, Xu J, Wang X, Liu J, Wu X, Fan W. Natural-source payloads used in the conjugated drugs architecture for cancer therapy: recent advances and future directions. Pharmacol Res 2024, 207.","DOI":"10.1016\/j.phrs.2024.107341"},{"key":"3127_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12951-022-01240-z","volume":"20","author":"X Tong","year":"2022","unstructured":"Tong X, Ga L, Ai J, Wang Y. Progress in cancer drug delivery based on AS1411 oriented nanomaterials. J Nanobiotechnol. 2022;20:57.","journal-title":"J Nanobiotechnol"},{"key":"3127_CR18","doi-asserted-by":"publisher","first-page":"6737","DOI":"10.2147\/IJN.S267177","volume":"15","author":"Z Yu","year":"2020","unstructured":"Yu Z, Li X, Duan J, Yang XD. Targeted treatment of Colon cancer with aptamer-guided albumin nanoparticles loaded with Docetaxel. Int J Nanomed. 2020;15:6737\u201348.","journal-title":"Int J Nanomed"},{"key":"3127_CR19","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1021\/jacs.9b10510","volume":"142","author":"J He","year":"2020","unstructured":"He J, Peng T, Peng Y, Ai L, Deng Z, Wang XQ, Tan W. Molecularly Engineering Triptolide with aptamers for high specificity and cytotoxicity for triple-negative breast Cancer. J Am Chem Soc. 2020;142:2699\u2013703.","journal-title":"J Am Chem Soc"},{"key":"3127_CR20","doi-asserted-by":"crossref","unstructured":"Chen Y, Yang J, Wang C, Wang T, Zeng Y, Li X, Zuo Y, Chen H, Zhang C, Cao Y et al. Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer. J Experimental Clin Cancer Res 2024, 43.","DOI":"10.1186\/s13046-024-03133-5"},{"key":"3127_CR21","doi-asserted-by":"crossref","unstructured":"Zhou D-d, Zhai X-t, Zhang L-w, Xie Z-h, Wang Y, Zhen Y-s. Gao R-j, Miao Q-f: a new TROP2-targeting antibody-drug conjugate shows potent antitumor efficacy in breast and lung cancers. Npj Precision Oncol 2024, 8.","DOI":"10.1038\/s41698-024-00584-z"},{"key":"3127_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/1878-0261.12166","volume":"12","author":"R Wang","year":"2018","unstructured":"Wang R, Li L, Zhang S, Li Y, Wang X, Miao Q, Zhen Y. A novel enediyne-integrated antibody\u2013drug conjugate shows promising antitumor efficacy against CD30\u2009+\u2009lymphomas. Mol Oncol. 2018;12:339\u201355.","journal-title":"Mol Oncol"},{"key":"3127_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jpha.2021.07.001","volume":"12","author":"Y-Y Wang","year":"2022","unstructured":"Wang Y-Y, Li L, Liu X-J, Miao Q-F, Li Y, Zhang M-R, Zhen Y-S. Development of a novel multi-functional integrated bioconjugate effectively targeting K-Ras mutant pancreatic cancer. J Pharm Anal. 2022;12:232\u201342.","journal-title":"J Pharm Anal"},{"key":"3127_CR24","doi-asserted-by":"publisher","first-page":"215860","DOI":"10.1016\/j.canlet.2022.215860","volume":"546","author":"L Qiu","year":"2022","unstructured":"Qiu L, Yue J, Ding L, Yin Z, Zhang K, Zhang H. Cancer-associated fibroblasts: an emerging target against esophageal squamous cell carcinoma. Cancer Lett. 2022;546:215860.","journal-title":"Cancer Lett"},{"key":"3127_CR25","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.apsb.2021.09.028","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang Y, Meng L. Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: new opportunities towards molecularly targeted therapy. Acta Pharm Sinica B. 2022;12:1054\u201367.","journal-title":"Acta Pharm Sinica B"},{"key":"3127_CR26","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1021\/acs.analchem.3c05122","volume":"96","author":"J Kong","year":"2023","unstructured":"Kong J, Ju X, Qi G, Wang J, Diao X, Wang B, Zhang C, Li J, Jin Y. Light-On fluorescent nanoprobes for monitoring dynamic distribution of Cellular Nucleolin during pyroptosis. Anal Chem. 2023;96:926\u201333.","journal-title":"Anal Chem"},{"key":"3127_CR27","doi-asserted-by":"crossref","unstructured":"Liu Y, Hu B, Pei X, Li J, Qi D, Xu Y, Ou H, Wu Y, Xue L, Huang JH et al. A Non-G\u2010Quadruplex DNA aptamer targeting NCL for diagnosis and therapy in bladder Cancer. Adv Healthc Mater 2023, 12.","DOI":"10.1002\/adhm.202300791"},{"key":"3127_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12032-015-0484-3","volume":"32","author":"J Qi","year":"2015","unstructured":"Qi J, Li H, Liu N, Xing Y, Zhou G, Wu Y, Liu Y, Chen W, Yue J, Han B, et al. The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomas. Med Oncol. 2015;32:45.","journal-title":"Med Oncol"},{"key":"3127_CR29","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.chembiol.2024.03.011","volume":"31","author":"X Fu","year":"2024","unstructured":"Fu X, Li J, Chen X, Chen H, Wang Z, Qiu F, Xie D, Huang J, Yue S, Cao C, et al. Repurposing AS1411 for constructing ANM-PROTACs. Cell Chem Biology. 2024;31:1290\u2013e13041297.","journal-title":"Cell Chem Biology"},{"key":"3127_CR30","doi-asserted-by":"crossref","unstructured":"Yan B, Li Y, He S. Aptamer-mediated therapeutic strategies provide a potential approach for cancer. Int Immunopharmacol 2024, 136.","DOI":"10.1016\/j.intimp.2024.112356"},{"key":"3127_CR31","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1021\/acs.bioconjchem.8b00456","volume":"29","author":"L Li","year":"2018","unstructured":"Li L, Hu L, Zhao C-y, Zhang S-h, Wang R, Li Y, Shao R-g. Zhen Y-s: the recombinant and reconstituted novel albumin\u2013lidamycin conjugate shows lasting Tumor Imaging and intensively enhanced therapeutic efficacy. Bioconjug Chem. 2018;29:3104\u201312.","journal-title":"Bioconjug Chem"},{"key":"3127_CR32","doi-asserted-by":"publisher","first-page":"43359","DOI":"10.1021\/acsami.3c07344","volume":"15","author":"W Ma","year":"2023","unstructured":"Ma W, Yang Y, Liu Z, Zhao R, Wan Q, Chen X, Tang B, Zhou Y, Lin Y. Self-assembled multivalent Aptamer Drug conjugates: enhanced targeting and cytotoxicity for HER2-Positive gastric Cancer. ACS Appl Mater Interfaces. 2023;15:43359\u201373.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3127_CR33","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.apsb.2023.01.017","volume":"13","author":"J He","year":"2023","unstructured":"He J, Duan Q, Ran C, Fu T, Liu Y, Tan W. Recent progress of aptamer\u2013drug conjugates in cancer therapy. Acta Pharm Sinica B. 2023;13:1358\u201370.","journal-title":"Acta Pharm Sinica B"},{"key":"3127_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21:85\u2013100.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3127_CR35","doi-asserted-by":"publisher","first-page":"113475","DOI":"10.1016\/j.biopha.2022.113475","volume":"153","author":"AC Ajibare","year":"2022","unstructured":"Ajibare AC, Ebuehi OAT, Adisa RA, Sofidiya MO, Olugbuyiro JAO, Akinyede KA, Iyiola HA, Adegoke YA, Omoruyi SI, Ekpo OE. Fractions of Hoslundia Opposita Vahl and hoslundin induced apoptosis in human cancer cells via mitochondrial-dependent reactive oxygen species (ROS) generation. Biomed Pharmacother. 2022;153:113475.","journal-title":"Biomed Pharmacother"},{"key":"3127_CR36","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1038\/s41418-021-00823-x","volume":"28","author":"S Uxa","year":"2021","unstructured":"Uxa S, Castillo-Binder P, Kohler R, Stangner K, M\u00fcller GA, Engeland K. Ki-67 gene expression. Cell Death Differ. 2021;28:3357\u201370.","journal-title":"Cell Death Differ"},{"key":"3127_CR37","doi-asserted-by":"crossref","unstructured":"Bai Y, Liang C, Zhou J, Liu Y, Wang F, Gao J, Wu J, Hu D. Development of novel celastrol-ligustrazine hybrids as potent peroxiredoxin 1 inhibitors against lung cancer. Eur J Med Chem 2023, 259.","DOI":"10.1016\/j.ejmech.2023.115656"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03127-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T01:27:35Z","timestamp":1738027655000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03127-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3127"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03127-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Ethics Committee of Anhui University of Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors of this study agreed to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}